论文部分内容阅读
目的探讨增效减毒汤对鼻咽癌放化疗患者的预后及不良反应的影响。方法选取2014年2月—2015年2月广州中医药大学顺德医院72例鼻咽癌放化疗患者,随机分为观察组和对照组,每组36例。其中,对照组给予维生素B12与庆大霉素治疗,观察组在对照组的治疗基础上给予增效减毒汤治疗,均治疗2~6周,比较两组预后效果和不良反应发生情况。结果观察组体质量下降率及放射性皮炎、骨髓抑制、恶心呕吐、腹泻等不良反应发生率均明显低于对照组(P<0.05),治疗总有效率86.11%明显高于对照组(P<0.05)。经2年随访,观察组无远处转移生存率94.44%明显高于对照组(P<0.05)。结论在鼻咽癌放化疗期间应用增效减毒汤治疗,可有效改善患者预后,减少不良反应的发生。
Objective To investigate the effect of Zeng Xiaotong Decoction on the prognosis and adverse reactions of patients with nasopharyngeal carcinoma treated by radiotherapy and chemotherapy. Methods 72 patients with nasopharyngeal carcinoma admitted to Shunde Hospital of Guangzhou University of Chinese Medicine from February 2014 to February 2015 were randomly divided into observation group and control group with 36 cases in each group. Among them, the control group was treated with vitamin B12 and gentamicin, and the observation group was treated with Zeng Xiaotu decoction on the basis of the control group, both of which were treated for 2 to 6 weeks. The prognosis and adverse reactions were compared between the two groups. Results The incidence of adverse reactions such as radiodermatitis, bone marrow suppression, nausea, vomiting and diarrhea in observation group were significantly lower than those in control group (P <0.05). The total effective rate was 86.11%, significantly higher than that in control group (P <0.05) ). After 2 years of follow-up, there was no distant metastasis in the observation group 94.44% survival rate was significantly higher than the control group (P <0.05). Conclusion The treatment of nasopharyngeal carcinoma during radiotherapy and chemotherapy with synergistic attenuated soup can effectively improve the prognosis of patients and reduce the incidence of adverse reactions.